TXG
10X Genomics Inc
97.70$
+4.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -161.0% | – | +188.7% | -131.2% | – | -48.4% | +144.0% | -5.6% | -35.9% | -35.0% | – | |
| – | +2.5% | -1.8% | -5.2% | -1.4% | -1.7% | -7.1% | -1.7% | +26.9% | -1.2% | -1.6% | -35.3% | – | |
| – | -3.3% | -7.2% | +6.5% | -12.7% | -3.1% | -4.5% | -11.3% | -8.3% | -0.2% | -10.2% | +13.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +5.5% | -136.9% | – | – | -110.6% | – | -289.8% | – | -41.5% | -71.5% | -176.7% | – | |
| – | -77.6% | -15.7% | +33.3% | +0.3% | -30.2% | -30.3% | -16.6% | -56.5% | +158.7% | -10.1% | -0.6% | – | |
| – | +167.3% | -18.8% | +12.4% | -130.3% | +1,326.0% | -96.3% | -50.4% | +837.3% | -79.5% | -27.4% | +490.0% | – | |
| – | +28.3% | -70.8% | +181.0% | -96.6% | +2,795.5% | -90.7% | +734.6% | -82.5% | +263.4% | -475.4% | – | – | |
| – | – | -107.9% | – | -23.7% | -395.0% | – | -37.4% | +69.5% | +17.9% | -60.4% | -25.1% | – | |
| – | – | -183.5% | – | +390.7% | -153.3% | – | -50.3% | +163.7% | -8.3% | -37.1% | -37.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.